US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...
Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
March 12, 2025 Lilly, J&J boosted spending on executive ... Eli Lilly's popular weight-loss and diabetes drugs Zepbound and Mounjaro in the United States. Pfizer on Thursday named James List ...
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will ... We view Lilly’s Mounjaro/Zepbound GLP-1/GIP drug as an ...
Investing.com -- Novo Nordisk 's (NYSE:NVO) (CSE:NOVOb) blockbuster weight-loss drug Wegovy may have difficulty securing approval from Medicare for coverage as a heart disease... In a recent ...
Bloomberg on MSN29d
Lilly to Spend $27 Billion to Bolster US Drug ManufacturingInsatiable demand and supply shortfalls left patients scrambling to find Lilly’s medications last year. Much of the active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback